Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

CME Eligible Sessions:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 50 of 225
Welcome and Session Overview for the Scott M. Hammer Workshop for New Researchers and Trainees   (ABSTRACT 1)
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
What Has the Advent of Capsid Inhibitors Taught Us About HIV Pathogenesis: Navigating Virology Presentations at CROI 2026
Stuart J. D. Neil
King's College London, London, UK
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026
John Frater
University of Oxford, Oxford, UK
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Long-Acting HIV Treatment Regimens: Where Are We and Where Are We Going? Navigating HIV Treatment Presentations at CROI 2026
Ruanne V. Barnabas
Massachusetts General Hospital, Boston, MA, USA
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Taking Prevention to the Population Level: Navigating Implementation Science Presentations at CROI 2026
Renee Heffron
University of Alabama at Birmingham, Birmingham, AL, USA
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Reclaiming the Narrative: Navigating Research Through Turbulent Times
Sunil S. Solomon
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Community Perspectives Video
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Clinical Trials in the Post-Lenacapavir Era   (ABSTRACT 7)
David V. Glidden
University of California San Francisco, San Francisco, CA, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Measurement of Outcomes in Health Care Delivery: Implementation Trials   (ABSTRACT 8)
Thomas A. Odeny
Washington University, St Louis, MO, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Accounting for User Choice: Preference Trials in HIV Prevention and Treatment Research   (ABSTRACT 9)
Elizabeth R. Brown
Fred Hutchinson Cancer Center, Seattle, WA, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Case Presentation With Panel Discussion, Plus Questions and Answers From the Audience   (ABSTRACT 6)
Sanjay Bhagani
Royal Free London NHS Foundation Trust, London, UK
Brenda E. Crabtree-Ramírez
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Andrew D. Kambugu
Infectious Disease Institute, Kampala, Uganda
Susanna Naggie
Durham VA Health Care System, Durham, NC, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Leveraging Artificial Intelligence for Spatial Analysis of Infectious Diseases   (ABSTRACT 5)
Jacob D. Estes
Oregon Health & Science University, Portland, OR, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Spatial Transcriptomic and Proteomic Profiling of HIV in Tissues   (ABSTRACT 2)
Zaza Ndhlovu
Africa Health Research Institute, Mtubatuba, South Africa
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Integrative Structural and Computational Approaches to RNA Biology   (ABSTRACT 3)
Megan Ken
The Scripps Research Institute, La Jolla, CA, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Latent HIV Reversal via Functional Genomics and Single-Cell Perturbation Modeling   (ABSTRACT 4)
Wei Li
University of Maryland, Baltimore, MD, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Welcome and Session Overview for the Scott M. Hammer Workshop for New Investigators and Trainees
from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
Virology: State of the Art and Navigating Presentations at CROI 2025
Stuart J.D. Neil
King's College London, London, UK
from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
Immunology: State of the Art and Navigating Presentations at CROI 2025
Lishomwa Ndhlovu
Weill Cornell Medicine, New York, NY, USA
from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
Prevention of HIV and STIs: State of the Art and Navigating Presentations at CROI 2025
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
HIV Treatment and Complications of HIV Disease: State of the Art and Navigating Presentations at CROI 2025
Judith S. Currier
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
HIV Cure Research: State of the Art and Navigating Presentations at CROI 2025
Joseph J. Eron, Jr
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
Message to New Investigators
from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
Liver Steatosis: New Nomenclature, New Tests, and New Drugs   (ABSTRACT 6)
Mandana Khalili
University of California San Francisco, San Francisco, CA, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Hepatitis B in the Gray Zone: Personalizing Treatment and Monitoring   (ABSTRACT 7)
Paul Y. Kwo
Stanford University, Stanford, CA, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Liver Cancer Surveillance: Who, How, When, and For How Long   (ABSTRACT 8)
Fasiha Kanwal
Baylor College of Medicine, Houston, TX, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Discussion with Audience Questions and Answers
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Using Machine Learning to Focus HIV Prevention Interventions   (ABSTRACT 9)
Carlos S. Saldana
Emory University, Atlanta, GA, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
HIV Prevention Efficacy Trial Design: Lessons From Recent Trials   (ABSTRACT 10)
Holly Janes
Fred Hutchinson Cancer Center, Seattle, WA, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
How Much Is Enough: The Importance of Pharmacokinetic Targets   (ABSTRACT 11)
Paolo Denti
University of Cape Town, Cape Town, South Africa
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Breaking the HIV Capsid: Atomic Force Microscopy Visualization   (ABSTRACT 2)
Juan R. Perilla
University of Delaware, Newark, DE, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Advances in Single-Cell Multiomic Profiling and Its Use in Virology and Immunology   (ABSTRACT 3)
Alexander Marson
University of California San Francisco, San Francisco, CA, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Visualizing Tissues: State-of-the-Art Single-Cell 3D Spatial Transcriptomics   (ABSTRACT 4)
Nikolaus Rajewsky
Berlin Institute for Medical Systems Biology, Berlin, Germany
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Advances in CRISPR-Cas Editing Methods and Their Use in Virology and Immunology   (ABSTRACT 5)
Angela R. Wahl
University of Alabama at Birmingham, Birmingham, AL, USA
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Case Presentations With Panel Discussion, Plus Questions and Answers From the Audience   (ABSTRACT 12)
Jose R. Arribas
Hospital La Paz Institute for Health Research, Madrid, Spain
Rachel A. Bender Ignacio
University of Washington, Seattle, WA, USA
Cecilia Kanyama
UNC Project, Lilongwe. Malawi
Juan Sierra-Madero
Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran, Mexico City, Mexico
Oana Sandulescu
Carol Davila University of Medicine and Pharmacy, București, Romania
from CROI 2025 on March 9, 2025 2:00 PM-4:00 PM
Overview of the Scott M. Hammer Workshop for New Investigators and Trainees   (ABSTRACT 1)
Serena S. Spudich
Yale University, New Haven, CT, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
The Evolving HIV Landscape: From the Unimaginable to the Imaginable Cure
Adam Castillejo
The London Patient, London, UK
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in Molecular Virology at CROI 2024
Frank Kirchhoff
Ulm University Medical Center, Ulm, Germany
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in SARS-CoV-2 and HIV Immunology at CROI 2024
Elizabeth Connick
University of Arizona, Tucson, AZ, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in HIV Cure at CROI 2024
Afam A. Okoye
Oregon Health and Sciences University, Portland, OR, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in HIV Prevention at CROI 2024
LaRon E Nelson
Yale University, New Haven, CT, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Navigating Presentations in Pediatric HIV at CROI 2024
Jennifer Jao
Northwestern University, Chicago, IL, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
From Early-Stage Investigator to Change Agent: Thoughts on Maximizing the Impact of Your Career
Jeanne M. Marrazzo
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2024 on March 3, 2024 8:30 AM-12:40 PM
Claudia P. Cortes
University of Chile, Santiago, Chile
Rajesh T. Gandhi
Massachusetts General Hospital, Boston, MA, USA
Overview of the Case-Based Workshop on Antiretroviral Therapy
Claudia P. Cortes
University of Chile, Santiago, Chile
Overview of the Case-Based Workshop on Antiretroviral Therapy
Rajesh T. Gandhi
Massachusetts General Hospital, Boston, MA, USA
Panel Discussion
Anchalee Avihingsanon
HIV-NAT, Bangkok, Thailand
Panel Discussion
Loice A. Ombajo
University of Nairobi, Nairobi, Kenya
Panel Discussion
Anton L. Pozniak
Chelsea and Westminster Hospital, London, UK
Panel Discussion
Janine M. Trevillyan
Doherty Institute for Infection and Immunity, Melbourne, Australia
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Discussion with Audience Questions and Answers
David L. Wyles
Denver Health Medical Center, Denver, CO, USA
Annie Luetkemeyer
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Steatotic Liver Disease in Persons Living With HIV   (ABSTRACT 6)
Jennifer C. Price
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Hepatitis Delta: What to Know, What to Do?   (ABSTRACT 7)
Kathrin van Bremen
University of Bonn, Bonn, Germany
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Cirrhosis Management   (ABSTRACT 8)
Mazen Noureddin
Houston Methodist Hospital, Houston, TX, USA
from CROI 2024 on March 3, 2024 1:30 PM-3:30 PM
Exploring Strategies to Measure and Understand Users' Preferences in HIV Prevention and Care   (ABSTRACT 10)
Christine Tagliaferri Rael
University of Colorado Anschutz Medical Campus, Aurora, CO, USA
from CROI 2024 on March 3, 2024 2:40 PM-3:15 PM
Hybrid Effectiveness Implementation Studies: Unrecognized Challenges and Emerging Directions   (ABSTRACT 11)
Elvin H. Geng
Washington University in St Louis, St Louis, MO, USA
from CROI 2024 on March 3, 2024 2:40 PM-3:15 PM
Stopping Clinical Trials Early: When and Why   (ABSTRACT 12)
Sally Hunsberger
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2024 on March 3, 2024 2:40 PM-3:15 PM
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 50 of 225